期刊文献+

不安腿综合征的药物治疗 被引量:5

Pharmacotherapy for restless legs syndrome
原文传递
导出
摘要 不安腿综合征是一种常见的神经系统感觉运动障碍疾病,常伴有睡眠障碍。它可见于任何年龄,因缺乏特异性的实验室辅助诊断依据,大多数患者在发病数年后仍不能被识别,甚至被误诊,更得不到适当治疗。过去的数十年里,多个大型临床研究证实,几种类型的药物可用来改善患者症状,包括多巴胺能药物、抗癫痫药物、鸦片类药物和苯二氮类药物。 Restless legs syndrome (RLS) is a common neurological sensor-motor alsoraer and often associated with a sleep complaint. RLS may begin at any ages. Because of lacking special evidence in laboratory, most of patients are unrecognized or misdiagnosed after symptoms onset years and also not treated properly. Large-scale clinical trials in patients with RLS have indicated that kinds of drugs could be used to improve the symptoms, including dopaminergics, anticonvulsants, opioids and benzodiazepines. This article review therapeutic studies and present it for the practical management of RLS.
作者 耿同超 史洁
出处 《临床药物治疗杂志》 2012年第6期39-43,共5页 Clinical Medication Journal
  • 相关文献

参考文献26

  • 1Fulda S,Wetter TC.Where dopamine meets opioids:a meta-analysis of theplacebo effect in restless legs syndrome treatment studies[J].Brain,2008,131:902-917.
  • 2Hening WA.Current guidelines and standards of practice for restless legssyndrome[J].Am J Med,2007,120:S22-S27.
  • 3Becker PM,Jamieson AO,Brown WD.Dopaminergic agents in restless legssyndrome and periodic limb movements of sleep:response and complicationsof extended treatment in 49 cases[J].Sleep,1993,16:713-716.
  • 4Collado-Seidel V,Kazenwadel J,Wetter TC,et al.A controlled study ofadditional sr-L-dopa in L-dopa-responsive restless legs syndrome withlate-night symptoms[J].Neurology,1999,52:285-290.
  • 5Garcia-Borreguero D,Stillman P,Benes H,et al.Algorithms for thediagnosis and treatment of restless legs syndrome in primary care[J].BMCNeurol,2011,11:28.
  • 6Partinen M,Hirvonen K,Jama L,et al.Open-label study of the long-termefficacy and safety of pramipexole in patients with Restless Legs Syndrome(extension of the PRELUDE study)[J].Sleep Med,2008,9:537-541.
  • 7Inoue Y,Kuroda K,Hirata K,et al.Long-term open-label study ofpramipexole in patients with primary restless legs syndrome[J].J Neurol Sci,2010,294:62-66.
  • 8Manconi M,Ferri R,Zucconi M,et al.Preferential D2 or preferential D3dopamine agonists in restless legs syndrome[J].Neurology,2011,77:110-117.
  • 9H gl B,Oertel WH,Stiasny-Kolster K,et al.Treatment of moderate tosevere restless legs syndrome:2-year safety and efficacy of rotigotinetransdermal patch[J].BMC Neurol,2010,10:86.
  • 10Oertel W,Trenkwalder C,Benes H,et al.Long-term safety and efficacy ofrotigotine transdermal patch for moderate-to-severe idiopathic restless legssyndrome:a 5-year open-label extension study[J].Lancet Neurol,2011,10:710-720.

同被引文献31

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部